These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8193427)

  • 21. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.
    Klahr S; Levey AS; Beck GJ; Caggiula AW; Hunsicker L; Kusek JW; Striker G
    N Engl J Med; 1994 Mar; 330(13):877-84. PubMed ID: 8114857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
    Svarstad E; Myking O; Ofstad J; Iversen BM
    Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The renally compromised older hypertensive: therapeutic considerations.
    Weder AB
    Geriatrics; 1991 Feb; 46(2):36-8, 43-8. PubMed ID: 1991620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure control according to the prevalence of diabetes in renal transplant recipients.
    Zbroch E; Malyszko J; Glowinska I; Maciorkowska D; Kobus G; Mysliwiec M
    Transplant Proc; 2013; 45(1):200-4. PubMed ID: 23375300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers.
    Galceran J; Plana J; Felip A; Pou G; Vila J; Sobrino J
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):751-7. PubMed ID: 20528630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insufficient therapeutic management of hypertensive patients with renal failure in France.
    P-Guérin A; Maumus-Robert S; Zin A
    Arch Cardiovasc Dis; 2008; 101(11-12):705-13. PubMed ID: 19059565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of arterial hypertension in developement of chronic renal failure].
    Kes P; Basić-Jukić N; Ljutić D; Brunetta-Gavranić B
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():78-84. PubMed ID: 23120821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials.
    Hsu CY
    J Hum Hypertens; 2001 Feb; 15(2):99-106. PubMed ID: 11317188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertensive nephropathy: prevention and treatment recommendations.
    Hart PD; Bakris GL
    Expert Opin Pharmacother; 2010 Nov; 11(16):2675-86. PubMed ID: 20718588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strict blood-pressure control and progression of renal failure in children.
    ; Wühl E; Trivelli A; Picca S; Litwin M; Peco-Antic A; Zurowska A; Testa S; Jankauskiene A; Emre S; Caldas-Afonso A; Anarat A; Niaudet P; Mir S; Bakkaloglu A; Enke B; Montini G; Wingen AM; Sallay P; Jeck N; Berg U; Caliskan S; Wygoda S; Hohbach-Hohenfellner K; Dusek J; Urasinski T; Arbeiter K; Neuhaus T; Gellermann J; Drozdz D; Fischbach M; Möller K; Wigger M; Peruzzi L; Mehls O; Schaefer F
    N Engl J Med; 2009 Oct; 361(17):1639-50. PubMed ID: 19846849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing blood pressure control in dialysis patients: finally a step forward.
    Hopkins K; Bakris GL
    Hypertension; 2009 Mar; 53(3):448-9. PubMed ID: 19153262
    [No Abstract]   [Full Text] [Related]  

  • 33. End-stage renal disease: a southern epidemic.
    Moore MA
    South Med J; 1994 Oct; 87(10):1013-7. PubMed ID: 7939913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ambulatory blood pressure monitoring assessment of blood pressure control in hypertension associated with chronic renal failure.
    Morduchowicz G; Zabludowski J; Wittenberg C; Winkler J; Boner G
    Nephrol Dial Transplant; 1993; 8(10):1169-71. PubMed ID: 8272233
    [No Abstract]   [Full Text] [Related]  

  • 35. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension and kidney damage.
    Griffin KA
    J Clin Hypertens (Greenwich); 2006 Mar; 8(3):209-14. PubMed ID: 16523000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertension and kidney disease: a deadly connection.
    Barri YM
    Curr Hypertens Rep; 2008 Feb; 10(1):39-45. PubMed ID: 18367025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. End-stage renal disease: why aren't improvements in hypertension treatment reducing the risk?
    Jaimes E; Galceran JM; Raij L
    Curr Opin Cardiol; 1996 Sep; 11(5):471-6. PubMed ID: 8889372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Remission of chronic kidney diseases. A realistic goal?].
    Mayer G
    Wien Klin Wochenschr; 2003 Jul; 115(12):405-6. PubMed ID: 12918182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.